342 related articles for article (PubMed ID: 19288298)
61. Characterization of PLGA microparticles as a drug carrier for 3-ethoxycarbonyl-2h-benzofuro[3,2-f]-1-benzopyran-2-one. Ultrastructural study of cellular uptake and intracellular distribution.
Gomes AJ; Faustino AS; Machado AE; Zaniquelli ME; de Paula Rigoletto T; Lunardi CN; Lunardi LO
Drug Deliv; 2006; 13(6):447-54. PubMed ID: 17002973
[TBL] [Abstract][Full Text] [Related]
62. Improved small molecule drug release from in situ forming poly(lactic-co-glycolic acid) scaffolds incorporating poly(β-amino ester) and hydroxyapatite microparticles.
Fisher PD; Palomino P; Milbrandt TA; Hilt JZ; Puleo DA
J Biomater Sci Polym Ed; 2014; 25(11):1174-93. PubMed ID: 24903524
[TBL] [Abstract][Full Text] [Related]
63. Poly(D,L-lactic-co-glycolic acid) microspheres for sustained delivery and stabilization of camptothecin.
Ertl B; Platzer P; Wirth M; Gabor F
J Control Release; 1999 Sep; 61(3):305-17. PubMed ID: 10477803
[TBL] [Abstract][Full Text] [Related]
64. Design and development of a novel controlled release PLGA alginate-pectinate polyspheric drug delivery system.
Sweet JL; Pillay V; Choonara YE
Drug Deliv; 2007 Jul; 14(5):309-18. PubMed ID: 17613019
[TBL] [Abstract][Full Text] [Related]
65. Modified emulsion solvent evaporation method for fabricating core-shell microspheres.
Xiao CD; Shen XC; Tao L
Int J Pharm; 2013 Aug; 452(1-2):227-32. PubMed ID: 23694803
[TBL] [Abstract][Full Text] [Related]
66. Tracking the in vivo release of bioactive NRG from PLGA and PEG-PLGA microparticles in infarcted hearts.
Pascual-Gil S; Simón-Yarza T; Garbayo E; Prosper F; Blanco-Prieto MJ
J Control Release; 2015 Dec; 220(Pt A):388-396. PubMed ID: 26546270
[TBL] [Abstract][Full Text] [Related]
67. Acidic microclimate pH distribution in PLGA microspheres monitored by confocal laser scanning microscopy.
Ding AG; Schwendeman SP
Pharm Res; 2008 Sep; 25(9):2041-52. PubMed ID: 18622692
[TBL] [Abstract][Full Text] [Related]
68. Jet milling--a new technique for microparticle preparation.
Nykamp G; Carstensen U; Müller BW
Int J Pharm; 2002 Aug; 242(1-2):79-86. PubMed ID: 12176228
[TBL] [Abstract][Full Text] [Related]
69. Subconjunctival Delivery of Dorzolamide-Loaded Poly(ether-anhydride) Microparticles Produces Sustained Lowering of Intraocular Pressure in Rabbits.
Fu J; Sun F; Liu W; Liu Y; Gedam M; Hu Q; Fridley C; Quigley HA; Hanes J; Pitha I
Mol Pharm; 2016 Sep; 13(9):2987-95. PubMed ID: 27336794
[TBL] [Abstract][Full Text] [Related]
70. In vitro degradation study of polyester microspheres by a new HPLC method for monomer release determination.
Giunchedi P; Conti B; Scalia S; Conte U
J Control Release; 1998 Dec; 56(1-3):53-62. PubMed ID: 9801429
[TBL] [Abstract][Full Text] [Related]
71. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
72. Controlled release of anti-inflammatory siRNA from biodegradable polymeric microparticles intended for intra-articular delivery to the temporomandibular joint.
Mountziaris PM; Sing DC; Chew SA; Tzouanas SN; Lehman ED; Kasper FK; Mikos AG
Pharm Res; 2011 Jun; 28(6):1370-84. PubMed ID: 21184147
[TBL] [Abstract][Full Text] [Related]
73. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.
Alonso MJ; Gupta RK; Min C; Siber GR; Langer R
Vaccine; 1994 Mar; 12(4):299-306. PubMed ID: 8178550
[TBL] [Abstract][Full Text] [Related]
74. Biodegradable microparticles for sustained release of a new GnRH antagonist--part I: Screening commercial PLGA and formulation technologies.
Schwach G; Oudry N; Delhomme S; Lück M; Lindner H; Gurny R
Eur J Pharm Biopharm; 2003 Nov; 56(3):327-36. PubMed ID: 14602174
[TBL] [Abstract][Full Text] [Related]
75. Effect of protein molecular weight on release from micron-sized PLGA microspheres.
Sandor M; Enscore D; Weston P; Mathiowitz E
J Control Release; 2001 Oct; 76(3):297-311. PubMed ID: 11578744
[TBL] [Abstract][Full Text] [Related]
76. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
[TBL] [Abstract][Full Text] [Related]
77. Formulation, characterization, and evaluation of ketorolac tromethamine-loaded biodegradable microspheres.
Sinha VR; Trehan A
Drug Deliv; 2005; 12(3):133-9. PubMed ID: 16025842
[TBL] [Abstract][Full Text] [Related]
78. Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems.
Luan X; Bodmeier R
J Control Release; 2006 Jan; 110(2):266-272. PubMed ID: 16300851
[TBL] [Abstract][Full Text] [Related]
79. Protein loaded biodegradable microspheres based on PLGA-protein bioconjugates.
Nam YS; Park TG
J Microencapsul; 1999; 16(5):625-37. PubMed ID: 10499842
[TBL] [Abstract][Full Text] [Related]
80. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid oligomers: Part II. Biodegradation and drug delivery application.
Wang N; Wu XS
J Biomater Sci Polym Ed; 1997; 9(1):75-87. PubMed ID: 9505204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
